Effect of pH and Citrate on Binding of Iron and Gallium by Transferrin in Serum

1992 ◽  
Vol 38 (9) ◽  
pp. 1883-1885 ◽  
Author(s):  
S J McGregor ◽  
J H Brock

Abstract Although both Al and Fe are bound to transferrin in plasma, they are metabolized differently. Aluminum is less tightly bound to transferrin than is Fe, and might be released in circumstances in which Fe remains bound. The effect of pH ana citrate on the binding of 67Ga (a radiotracer used as an analog of Al) to transferrin in normal human serum was tested in the presence of physiological concentrations of CO2. At pH less than 6.8, Ga started to dissociate from transferrin; at pH 6, greater than 50% of the added 67Ga was present in a low-M(r) form. In contrast, almost all Fe remained bound to transferrin at pH values as low as 4.7. Citrate at concentrations as great as 100 mmol/L had no effect on binding of Fe, but the binding of 67Ga was markedly reduced at citrate greater than 1 mmol/L. Being bound to transferrin less strongly than Ga is, Al could dissociate even more readily, and loss of Al from transferrin in the kidney might explain why Al but not Fe is excreted in urine.

1982 ◽  
Vol 28 (1) ◽  
pp. 119-121 ◽  
Author(s):  
E Piall ◽  
G W Aherne ◽  
V Marks

Abstract We evaluated a commercially available (Diagnostic Biochemistry Inc.) doxorubicin 125I radioimmunoassay kit. This kit gave a high apparent doxorubicin concentration (greater than 12 micrograms/L), which was not linearly related to dilution, for two pools of normal human serum and plasma and also for samples collected from patients before they received the drug. In contrast, a doxorubicin 3H radioimmunoassay developed by us gave a low blank (2 micrograms/L), which was linearly related to dilution, for the same pools and patients' samples. Doxorubicin concentrations in the plasma of patients receiving the drug were compared by the two methods; the kit gave results five- to 10-fold those obtained with our assay. High nonspecific interference by serum and plasma as measured by the 125I radioimmunoassay must therefore be borne in mind by users of the kit, and we suggest that results should be corrected for these nonspecific effects.


Biochemistry ◽  
1963 ◽  
Vol 2 (2) ◽  
pp. 286-289 ◽  
Author(s):  
Walter N. Shaw ◽  
Eldon W. Shuey

2003 ◽  
Vol 10 (2) ◽  
pp. 216-220
Author(s):  
Marlene Pereira de Carvalho Florido ◽  
Patrícia Ferreira de Paula ◽  
Lourdes Isaac

ABSTRACT Due to the increasing numbers of reported clinical cases of complement deficiency in medical centers, clinicians are now more aware of the role of the complement system in the protection against infections caused by microorganisms. Therefore, clinical laboratories are now prepared to perform a number of diagnostic tests of the complement system other than the standard 50% hemolytic component assay. Deficiencies of alternative complement pathway proteins are related to severe and recurrent infections; and the application of easy, reliable, and low-cost methods for their detection and distinction are always welcome, notably in developing countries. When activation of the alternative complement pathway is evaluated in hemolytic agarose plates, some but not all human sera cross-react to form a late linear lysis. Since the formation of this linear lysis is dependent on C3 and factor B, it is possible to use late linear lysis to routinely screen for the presence of deficiencies of alternative human complement pathway proteins such as factor B. Furthermore, since linear lysis is observed between normal human serum and primary C3-deficient serum but not between normal human serum and secondary C3-deficient serum caused by the lack of factor H or factor I, this assay may also be used to discriminate between primary and secondary C3 deficiencies.


1987 ◽  
Vol 15 (3) ◽  
pp. 255-259 ◽  
Author(s):  
Jorge R. Geffner ◽  
Mirta Giordano ◽  
Graciela P. Serebrinsky ◽  
Marina S. Palermo ◽  
Martin A. Isturiz

Sign in / Sign up

Export Citation Format

Share Document